Fa-ChyiLeeMD

Oncology • Orange, CA

Professor, Department of Internal Medicine Chief, Section of Gastrointestinal Oncology, Department of Internal Medicine University of New Mexico Cancer Center

Join to view full profile

Dr. Lee is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Lee's full profile

Already have an account?

Office
101 The City Dr S
Bldg 23
Orange, CA 92868
Phone+1 714-456-8000

Fax+1 714-456-3765

Education & Training

UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1994 - 1997
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 1991 - 1994
Saint Louis University School of MedicineClass of 1991

Certifications & Licensure

CA State Medical License 1993 - 2025
NM State Medical License 1999 - 2018
TX State Medical License 1997 - 2004

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2014

Clinical Trials

Combination Paclitaxel, Carboplatin and Temozolomide Start of enrollment: 2003 Nov 01
Completed
Phase 1
Combination of Oxaliplatin, Capecitabine, and Celecoxib With Concurrent Radiation for Rectal Cancer Start of enrollment: 2005 Apr 01
Terminated
Phase 2
Combination Therapy With 5-Fluorouracil, Interferon-an Interleukin-2, & Thalidomide for Metastatic, Advanced or Recurrent Renal Cell Carcinoma Start of enrollment: 2000 Sep 01
Completed
Phase 1, Phase 2
Chart Review: Unresectable/Metastatic Cholangiocarcinoma Treated With Irinotecan, Capecitabine and Celecoxib Start of enrollment: 2005 Nov 01
Terminated
INST 0603C Patients With Unresectable/Metastatic Pancreatic Cancer Treated in the UNM Cancer Start of enrollment: 2006 Sep 01
Terminated
Bevacizumab (Avastin) Induced Hypertension and Correlation With Tumor Response, a Chart Review Start of enrollment: 2006 Feb 01
Terminated
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Start of enrollment: 2008 Aug 08
Active, not recruiting
Phase 3
Compassionate Use of Mifepristone in Brain/Nervous System and Other Cancers Start of enrollment: 2008 Nov 01
Terminated
Not Applicable
Combination of Irinotecan, Oxaliplatin and Cetuximab for Locally Advanced or Metastatic Pancreatic Cancer Start of enrollment: 2008 Oct 01
Completed
Phase 2
Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer Start of enrollment: 2010 Feb 15
Completed
Phase 3
Irinotecan Hydrochloride and Cetuximab With or Without Ramucirumab in Treating Patients With Advanced Colorectal Cancer With Progressive Disease After Treatment With Bevacizumab-Containing Chemotherapy Start of enrollment: 2011 Jan 18
Completed
Phase 2
Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery Start of enrollment: 2014 Feb 01
Completed
Phase 2
Irinotecan and Capecitabine as Second-line Treatment for Advanced/Metastatic Biliary Tract Cancers Start of enrollment: 2015 Nov 01
Withdrawn
Phase 2
Join now to see all

Publications & Presentations

PubMed

1 citations
A phase II study of cabozantinib and pembrolizumab in advanced gastric/gastroesophageal adenocarcinomas resistant or refractory to immune checkpoint inhibitors.
Farshid Dayyani, Joseph Chao, Fa-Chyi Lee, Thomas H Taylor, Kristen Neumann
The Oncologist. 2024-08-05
Hereditary Cancer Clinics Improve Adherence to NCCN Germline Testing Guidelines for Pancreatic Cancer.
Claudia Rosso, Naomie Devico Marciano, Deepika Nathan, Wen-Pin Chen, Christine E McLaren
Journal of the National Comprehensive Cancer Network. 2024-06-18
A case report of challenges in distinguishing gastroesophageal junction hepatoid adenocarcinoma from testicular germ cell tumor: Insights for improved diagnosis with g...
Omid Yazdanpanah, Fa-Chyi Lee, Roozbeh Houshyar, Mahra Nourbakhsh, Nataliya Mar
SAGE Open Medical Case Reports. 2024-01-01

Professional Memberships

American Society of Clinical Oncology - ASCO
Member